Глава 6. Другие лекарственные средства: психостимуляторы, β-адреноблокаторы, клонидин, дисульфирам, донепезил и такрин.
Литература.
Психостимуляторы.
Обзор
Chiarello RJ, Cole JO. The use of psychostimulants in general psychiatry. Arch Gen Psychiatry 1987; 44:286.
Терапевтические показания
Forrest WH Jr, Brown BW Jr, Brown CR, et al. Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med 1977; 296:712.
Katon W, Raskind M. Treatment of depression in the medically ill elderly with methylphenidate. Am J Psychiatry 1980; 137:963.
Kaufmann MW, Marray GB, Cassem NH. Use of psychostimulants in medically ill depressed patients. Psychosomatics 1982; 23:817.
Mannuzza S, Klein EG, Bessler A, et al. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993; 50:885.
Mattes JA, Boswell L, Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 1984; 41:1059.
Spencer T, Wilens ТЕ, Biederman J, et al. A double-blind, cross-over comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Arch Gen Psychiatry 1995; 52:434.
Spencer T, Biederman J, Wilens ТЕ, et al. Is attention deficit hyperactivity disorder in adults a valid diagnosis? Harvard Rev Psychiatry 1994; 1:326.
Wender PH, Reimherr FW, Wood DR. Attention deficit disorder ("minimal brain dysfunction") in adults. Arch Gen Psychiatry 1981; 38:449.
Wender PH, Reimherr FW, Wood D, Ward M. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 1985; 142:547.
Wilens ТЕ, Biederman J, Spencer TJ, et al. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 1999; 19:257.
Wood DR, Reimherr FW, Wender PH, et al. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry 1976; 33:1453.
β-адреноблокаторы.
Лечение тревоги
James I, Pearson R, Griffith D, et al. Effect of oxprenolol on stage fright in musicians. Lancet 1977; 2:952.
Kathol R, Noyes R Jr, Slymen DJ, et al. Propranolol in chronic anxiety disorders: a controlled study Arch Gen Psychiatry 1981; 37:1361.
Лечение приступов ярости
Greendyke RM, Schuster DB, Wooton JA. Propranolol in the treatment of assaultive patients with organic brain disease. J Clin Psychopharmacol 1984; 4:282.
Mattes JA. Metoprolol for intermittent explosive disorder. Am J Psychiatry 1985; 142:1108.
Ratey JJ, Morrill R, Oxenkrug G. Use of propranolol for provoked and unprovoked episodes of rage. Am J Psychiatry 1983; 140:1356.
Ratey JJ, Sorgi P, O'Driscoll GA, et al. Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind, placebo-controlled study. J Clin Psychiatry 1992; 53:41.
Лечение акатизии
Lipinski JF, Zubenko GS, Cohen BM, et al. Propranolol in the treatment of neuroleptic-induced akathisia. Am J Psychiatry 1984; 141:412.
Ratey JJ, Sorgi P, Polakoff S. Nadolol as a treatment for akathisia. Am J Psychiatry 1985; 142:640.
Лечение алкогольной абстиненции
Kraus ML, Gottlieb LD, Horwitz RI, et al. Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med 1985; 313:905.
Побочные эффекты
Dimsdale JE, Newton RP, Joist T. Neuropsychological side effects of beta-blockers. Arch Intern Med 1989; 149:514.
Griffin SJ, Friedman MJ. Depressive symptoms in propranolol users. J Clin Psychiatry 1986; 47:453.
Клонидин
Adier LA, Angrist B, Peselow E, et al. Clonidine in neuroleptic-induced akathisia. Am J Psychiatry 1987; 144:235.
Bond WS. Psychiatric indications for clonidine: the neuropharmacologic and clinical basis. J Clin Psychopharmacol 1986; 6:81.
Cohen DJ, Detlor J, Young JG, et al. Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980; 37:1350.
Franks P, Harp J, Bell B. Randomized, controlled trial of clonidine for smoking cessation in a primary care setting. JAMA 1989; 262:3011.
Giannini AJ, Pascarzi GA, Loiselle RH, et al. Comparison of clonidine and lithium in the treatment of mania. Am J Psychiatry 1986; 113:1608.
Goodman WK, Charney DS, Price LH, et al. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases. Am J Psychiatry 1986; 143:900.
Hardy MC, Lecrubier Y, Widlocher D. Efficacy of clonidine in 24 patients with acute mania. Am J Psychiatry 1986; 143:1450.
Jouvent R, Lecrubier Y, Puech AJ, et al. Antimanic effect of clonidine. Am J Psychiatry 1980; 137:1275.
Leckman JF, Hardin MT, Riddle MA. Clonidine treatment of Gilles de la Tourette's Syndrome. Arch Gen Psychiatry 1991; 48:324.
San L, Cami J, Peir JM, et al. Efficacy of clonidine, guanfacine and methadone is the rapid detoxification of heroin addicts: a controlled clinical trial. Br J Addict 1990; 85:141.
Zubenko GS, Cohen BM, Lipinski JF, et al. Use of clonidine in treating neuroleptic-induced akathisia. Psychiatry Res 1984; 13:253.
Zubenko GS, Cohen BM, Lipinski JF, et al. Clonidine in the treatment of mania and mixed bipolar disorder. Am J Psychiatry 1984; 141:1617.
Верапамил.
Barton BM, Gitlin MJ. Verapamil in treatment-resistant mania: an open trial. J Clin Psychopharmacol 1987; 7:101.
Dubovsky SL, Franks RD, Lifschitz M, et al. Effectiveness of verapamil in the treatment of a manic patient. Am J Psychiatry 1982; 139:502.
Dubovsky SL, Franks RD, Allen S, et al. Calcium antagonists in mania: a double-blind study of verapamil. Psychiatry Res 1986; 18:309.
Giannini AJ, Houser WL, Loiselle RH, et al. Antimanic effects of verapamil. Am J Psychiatry 1984; 141:1602.
Gitlin M, Weiss J. Verapamil as maintenance treatment in bipolar illness: a case report. J Clin Psychopharmacol 1984; 4:341.
Дисульфирам.
Branchey L, Davis W, Lee KK, et al. Psychiatric complications of disulfiram treatment. Am J Psychiatry 1987; 14:1310.
Eneanya DL, Bianchine JR, Duran DO, et al. The actions and metabolic fate of disulfiram. Ann Rev Pharmacol Toxicol 1981; 21:575.
Fisher CM. Catatonia due to disulfiram toxicity. Arch Neurol 1989; 46:798.
Fuller RK, Branchey L, Brightwell DR, et al. Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. JAMA 1986; 256:1449.
Fuller RK, Roth HP. Disulfiram for the treatment of alcoholism. Ann Intern Mod 1979; 90:901.
Kirubakaran V, Liskow B, Mayfield D, et al. Case report of acute disulfiram overdose. Am J Psychiatry 1983; 140:1513.
Sellers EM, Naranjo СA, Peachey JE. Drugs to decrease alcohol consumption. N Engl J Med 1981; 305:1255.
Донепезил.
Roger SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: result of a multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group. Dementia 1996; 7:293.
Такрин.
Knapp MJ, Knopman DS, Solomon PR, et al. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994; 271:985.
Watkins PB, Zimmerman HJ, Knapp MJ, et al. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994; 271:992.
Аддерал.
Pelham WE, Aronoff HR, Midlam JK, et al. A comparison of ritalin and Adderall: efficacy and time course in children with attention-deficit/hyperactivity disorder. Pediatrics 1999; 103:43.
Pliszka SR. The use of psychostimulants in the pediatric patient. Pediatr Clin North Am 1998; 45:1085.
Swanson J, Wigal S, Greenhill L, et al. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting. Psychopharmacol Bull 1998; 34:55.
